Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2004, p. 4911-4914, Vol. 48, No. 12
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.12.4911-4914.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Need for Early Antifungal Treatment Confirmed in Experimental Disseminated Candida albicans Infection
Donna M. MacCallum and
Frank C. Odds*
Aberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, Aberdeen, United Kingdom
Received 14 May 2004/
Returned for modification 18 June 2004/
Accepted 8 August 2004
Groups of mice infected intravenously with Candida albicans were treated intraperitoneally with amphotericin B, caspofungin, or fluconazole, starting at intervals before and after challenge. Survival was longest and tissue burdens were most reduced with early treatment, and survival times fell proportionately as treatment was delayed, reinforcing clinical recommendations for the earliest possible initiation of antifungal therapy.
* Corresponding author. Mailing address: FRCPath, Aberdeen Fungal Group, Institute of Medical Sciences, Aberdeen AB25 2ZD, United Kingdom. Phone and fax: 44 1224 555828. E-mail:
f.odds{at}abdn.ac.uk.
Antimicrobial Agents and Chemotherapy, December 2004, p. 4911-4914, Vol. 48, No. 12
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.12.4911-4914.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Tavares, P. M., Thevissen, K., Cammue, B. P. A., Francois, I. E. J. A., Barreto-Bergter, E., Taborda, C. P., Marques, A. F., Rodrigues, M. L., Nimrichter, L.
(2008). In Vitro Activity of the Antifungal Plant Defensin RsAFP2 against Candida Isolates and Its In Vivo Efficacy in Prophylactic Murine Models of Candidiasis. Antimicrob. Agents Chemother.
52: 4522-4525
[Abstract]
[Full Text]
-
Brown, S. D., Traczewski, M. M.
(2008). Caspofungin Disk Diffusion Breakpoints and Quality Control. J. Clin. Microbiol.
46: 1927-1929
[Abstract]
[Full Text]
-
Hope, W. W., Drusano, G. L., Moore, C. B., Sharp, A., Louie, A., Walsh, T. J., Denning, D. W., Warn, P. A.
(2007). Effect of Neutropenia and Treatment Delay on the Response to Antifungal Agents in Experimental Disseminated Candidiasis. Antimicrob. Agents Chemother.
51: 285-295
[Abstract]
[Full Text]
-
Warn, P. A., Sharp, A., Mosquera, J., Spickermann, J., Schmitt-Hoffmann, A., Heep, M., Denning, D. W.
(2006). Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother
58: 1198-1207
[Abstract]
[Full Text]
-
Saville, S. P., Lazzell, A. L., Bryant, A. P., Fretzen, A., Monreal, A., Solberg, E. O., Monteagudo, C., Lopez-Ribot, J. L., Milne, G. T.
(2006). Inhibition of filamentation can be used to treat disseminated candidiasis.. Antimicrob. Agents Chemother.
50: 3312-3316
[Abstract]
[Full Text]
-
Golan, Y., Wolf, M. P., Pauker, S. G., Wong, J. B., Hadley, S.
(2005). Empirical Anti-Candida Therapy among Selected Patients in the Intensive Care Unit: A Cost-Effectiveness Analysis. ANN INTERN MED
143: 857-869
[Abstract]
[Full Text]